phenyl acetate has been researched along with Chronic Kidney Failure in 248 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 106 (42.74) | 18.7374 |
1990's | 59 (23.79) | 18.2507 |
2000's | 45 (18.15) | 29.6817 |
2010's | 35 (14.11) | 24.3611 |
2020's | 3 (1.21) | 2.80 |
Authors | Studies |
---|---|
Aghai, F; De Vlieger, G; Debaveye, Y; Isberner, N; Klinker, H; Kraus, S; Kuypers, D; Spriet, I; Van Daele, R | 1 |
Chamberlain, S; Mole, DR; Protheroe, A; Purshouse, K; Soares, M; Tuthill, M | 1 |
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
Gao, CQ; Tan, YY; Tong, CJ; Zhou, JJ | 1 |
Bruzzese, A; Buemi, M; Caccamo, D; Canale, V; Cernaro, V; Costantino, G; Lucisano, S; Santoro, D | 1 |
Askelson, M; Flanagan, B; Gibson, S; Hantash, J; Hendon, KS; Larkin, JW; Maddux, FW; Newman, GE; Smith, WB; Thadhani, RI; Usvyat, LA; Zhao, J | 1 |
Aguilera, D; Albaret, J; Correia, EDC; Kosmadakis, G; Somda, F | 1 |
Huynh, T; Nguyen, T; Pham, T | 1 |
Curtis, AB; Gudleski, GD; Krahn, RE; Lambert, J; Murray, B; Muscarella, M; Panesar, M; Rajagopalan, B; Su, W; Tulowitzki, R | 1 |
Oh, MS; Uribarri, J | 1 |
Gennari, FJ; Sargent, JA | 1 |
Behets, GJ; D'Haese, PC; De Schutter, TM; Geryl, H; Gundlach, K; Neven, E; Passlick-Deetjen, J; Peter, ME; Steppan, S | 1 |
Golubev, RV; Korosteleva, NIu; Kostereva, EM; Lazeba, VA; Lebedeva, EB; Levykina, EN; Nesterova, OB; Smirnov, AV; Starosel'skiĭ, KG; Suglobova, ED; Vasil'ev, AN; Vasil'eva, IA; Verbitskaia, EV | 1 |
Büschges-Seraphin, B; Covic, A; de Francisco, AL; Ghenu, A; Kroczak, M; Marzell, B; Passlick-Deetjen, J; Ponce, P | 1 |
Harada, M; Matsuzaki, K; Takeuchi, M | 1 |
St Peter, WL; Weinhandl, ED; Yusuf, AA | 1 |
Alfieri, T; Anum, EA; Braunhofer, P; Newsome, B; Ramakrishnan, K; Wang, S | 1 |
Galani, VJ; Prajapati, VA; Shah, PR | 1 |
Behets, GJ; Büchel, J; D'Haese, PC; Dams, G; De Schutter, TM; Gundlach, K; Neven, E; Passlick-Deetjen, J; Steppan, S | 1 |
Hernández-Jaras, J; Pons-Prades, R; Sánchez-Canel, JJ | 1 |
Akoglu, E; Arikan, H; Cakalagaoglu, F; Ozener, C; Tuglular, S; Tugtepe, H; Yucel, SK | 1 |
Bigazzi, R; Casani, A; Di Giorgio, A; Grazi, G; Manca Rizza, G; Migliori, M; Panichi, V; Paoletti, S; Rosati, A; Ruggeri, M; Scatena, A; Sgambato, A | 1 |
Abraham, JD; Arfeen, SS; Bowline, IG; Chernin, G; Dwyer, JP; Fadem, SZ; Goral, S; Greene, T; Koury, M; Lewis, JB; Middleton, J; Sika, M; Sinsakul, MV; Umanath, K; Van Buren, PN; Weiner, DE | 1 |
Arroyo, RA; Carretero, MP; Cobo, PA; Díaz, MO; Ortiz, Pde S; Pérez-García, R; Prats, EC; Ramón, MA | 1 |
Copland, M; Komenda, P; McCullough, PA; Morfin, JA; Weinhandl, ED | 1 |
Ezzat Zadegan, S; Mahmudpour, M; Pakfetrat, M; Raiss Jalali, GA; Roozbeh, J; Sagheb, MM | 1 |
Caputo, F; Chasan-Taber, S; Duggal, A; Evenepoel, P; Fan, S; Foggensteiner, L; Heaf, JG; Kelly, A; Ortiz, A; Selgas, R | 1 |
De Vos, JY; Elseviers, M | 1 |
Hutchison, AJ; Mohammed, I | 1 |
Khan, DA; Khan, FA; Saif, I | 1 |
Alvarez de Lara, MA; Coll, E; Galcerán, J; García-Osuna, R; Llopis, R; Martín de Francisco, AL; Martín-Malo, A; Martínez-Castelao, A; Pérez-García, R; Sánchez, B | 1 |
Ando, Y; Ito, C; Kusano, E; Maeda, T; Momoi, M; Muto, S; Saito, O; Saito, T; Yamagata, T | 1 |
Fan, Q; Liu, J; St Peter, WL; Weinhandl, E | 2 |
Gotch, F; Kotanko, P; Levin, NW | 1 |
Assimon, MM; Mousa, S; Pai, AB; Shaker, O | 1 |
Noto, L | 1 |
Accalai, G; Bolasco, P; Calvisi, L; Carpentieri, E; Contu, R; Corazza, L; Fundoni, GF; Gazzanelli, L; Ghezzi, PM; Grussu, S; Mattana, G; Pinna, M; Piras, A; Pistis, R; Scalas, MR; Serra, A; Sulis, E | 1 |
Kim, TH; Yang, SY | 1 |
Barreto, DV; Barreto, F; Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB | 1 |
Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ | 1 |
Shinoda, T; Tomo, T | 1 |
Diab, R; Hmida, J; Le Roy, F; Mercadal, L; Petitclerc, T | 1 |
Chandraker, A; Grafals, M; Rennke, HG; Riella, LV | 1 |
Tomo, T | 1 |
Brenchley, PE; Hutchison, AJ; Smith, CP | 1 |
Bledsoe, AL; Kaplan, MR; McGowan, J; Stashenko, CL | 1 |
Cleveland, M | 1 |
Cerezo, S; Hervás, JG; Prados, D | 1 |
Neme, G; Peñalba, A; Tirado, S | 1 |
Bleyer, AJ | 1 |
Nolan, CR; Qunibi, WY | 3 |
Ksiazek, A; Swatowski, A; Załuska, WT | 1 |
BRANCACCIO, A; D'ALESSANDRO, B; DE LUCA, R; JACONO, G; LA FIANZA, F; PALUMBO, E | 1 |
Paret, CL | 1 |
Kissner, PZ; Migdal, SD; Penumalee, S | 1 |
Bommer, J; Chertow, GM; Raggi, P | 1 |
Barrett, PH; Berger, R; Bisschop, PH; de Barse, MM; de Boer, J; de Sain-van der Velden, MG; Prinsen, BH; Rabelink, TJ; Romijn, JA; van Haeften, TW | 1 |
Renders, L; Schoecklmann, H; Walcher, J | 1 |
Daly, C; MacLeod, AM; Rabindranath, KS; Roderick, P; Strippoli, GF; Wallace, SA | 1 |
Cobanoglu, B; Coskun, B; Karincaoglu, Y; Ozturk, P; Saral, Y | 1 |
Benador, N; Greenbaum, LA; Grenda, R; Melnick, JZ; Paredes, A; Qiu, P; Restaino, I; Salusky, IB; Williams, LA; Wojtak, A | 1 |
Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
Little, G; Otoo, A | 1 |
Abu-Alfa, AK; Brewster, UC; Ciampi, MA; Reilly, RF | 1 |
Bellinghieri, G; Calò, LA; Monardo, P; Santoro, D; Savica, V | 1 |
Bellasi, A; Block, GA; Galassi, A; Raggi, P; Spiegel, DM | 1 |
Elsharkawy, MM; Youssef, AM; Zayoon, MY | 1 |
Chou, CY; Huang, CC; Kuo, HL; Liao, PY; Lin, HH; Lin, PW; Liu, JH; Liu, YL; Yang, YF; Yu, CC | 1 |
Ekşioğlu-Demiralp, E; Ercan, F; Gedik, N; Sakarcan, A; Sehirli, O; Sener, E; Sener, G; Yeğen, BC | 1 |
Budoff, MJ; Gao, YL; Kessler, P; Mao, SS; Moustafa, M; Qunibi, W | 1 |
Tonelli, M; Winkelmayer, WC | 1 |
Coll, E; Jofré, R; López-Gómez, JM; Martínez Miguel, P; Ortega, M; Pérez-García, R; Rodríguez-Benítez, P | 1 |
Mitchell, A; Van Stone, JC | 1 |
Botterman, P; Kopp, KF; Kramer, I; Kuhlencordt, M; Melamed, J | 1 |
Bernard, DB; Idelson, BA; Liang, C; Redline, RC; Schick, EC | 1 |
Barnes, CC; Hoda, P; Lennox, G; Martin, J; McNeaney, H; Mukherjee, J; Sackett, DL; Shimizu, AG; Smith, EK; Taylor, DW | 1 |
Hosokawa, S; Kohira, S; Nishio, T; Tomoyoshi, T | 1 |
Cooper, JH; Reichard, GA; Sigler, MH; Skutches, CL; Teehan, BP | 1 |
Bigi, L; Bovio, G; Galli, F; Petrella, E; Pezzagno, G; Piazza, V; Picardi, L; Poggio, F; Salvadeo, A; Segagni, S; Villa, G | 1 |
Kobayashi, N; Marumo, F; Nakamura, H; Okubo, M | 1 |
Chappell, TR; Henrich, WL; Hunt, JM; Rubin, LJ | 1 |
Hampl, H; Kessel, M; Mahiout, A | 1 |
Hampi, H; Kessel, M; Mahiout, A | 1 |
Bovio, L; Galli, F; Grosoli, M; Petrella, E; Piazza, V; Picardi, L; Poggio, F; Salvadeo, A; Segagni, S; Villa, G | 1 |
Faller, B; Marichal, JF | 1 |
Bruno, R; Cano, JP; Grandvuillemin, M; Olmer, M | 1 |
Liomin, E; Schneider, H; Streicher, E | 1 |
Buda, AJ; Farrel, S; Leenen, FH; Levine, DZ; Smith, DL; Uldall, PR | 1 |
Amiel, C; Benyahia, A; Blanchet, F; Cramer, E; Georges, R; Kanfer, A; Méry, JP | 1 |
Berkseth, R; Keshaviah, P; Kjellstrand, C; Luehmann, D; McMichael, C | 1 |
Burgess, WP; Chandler, JT; Diaz-Buxo, JA; Farmer, CD; Holt, KL; Walker, PJ | 1 |
Ajima, H; Hirai, H; Matsuzaki, H; Nishizawa, S; Sakai, M; Seki, K; Shiomi, S; Suzuki, M; Yabuki, S; Yajima, H | 1 |
Maierhofer, WJ; Piering, WF; Quebbeman, EJ | 1 |
Wehle, B | 1 |
Bryant, RE; Kaiser, BA; Potter, DE; Vreman, HJ; Weiner, MW | 1 |
Burns, CB; Scheinhorn, DJ | 1 |
Hakim, RM; Lowrie, EG | 1 |
Bolisay, C; Kramer, M; Krug, M; Raja, R; Rosenbaum, JL | 1 |
Barril, G; de Vinuesa, SG; Gonzalez, C; Junco, E; Luño, J; Resano, M; Valderrabano, F | 1 |
Bassi, S; Bigi, L; Brandi, F; Castellani, A; Doregatti, C; Lonati, F; Minari, M; Poiatti, P | 1 |
Esguerra, FA | 1 |
Janicka, L; Sokołowska, G; Twardowski, Z | 1 |
Dávid, MF; Farkas, L; Karátson, A; Kocsis, B; Rácz, L | 1 |
Aid, J; Craske, H; Kennedy, I; Levine, D; Porrett, E; Uldall, PR; Woods, F | 1 |
Briggs, WA; Mahajan, SK; McDonald, FD; Pedersen, MM; Prasad, AS; Sillix, DH | 1 |
Crowther, A; Laker, MF; Mansell, MA; Wing, AJ | 1 |
DuBose, TD | 1 |
Davidson, WD; Dolan, MJ; Wasserman, K; Weitzman, RE; Whipp, BJ | 1 |
Hirata, S; Horiuchi, N; Kishimoto, T; Maekawa, M; Mizutani, Y; Nishitani, H; Yamakawa, M; Yamamoto, T; Yatsuboshi, M | 1 |
Nissenson, AR | 1 |
Heierli, C; Thölen, H | 1 |
Casino, F; Guerricchio, G; Lopez, T; Sacco, A; Scandiffio, T; Trentadue, A | 1 |
Jahn, HA; Klein, S; Mitsuishi, Y; Schohn, DC | 1 |
Bosch, JP; Gotch, FA; Kjellstrand, CM; Maher, JF; Scribner, BH | 1 |
Ahmad, S; Haas, L; Pagel, M; Sherrard, D | 1 |
Monnens, LA; Schröder, CH; Swinkels, DW; Verschuur, R; Willems, HL | 1 |
Błaszczyk, J; Kedziora, J; Luciak, M; Pawlicki, L; Sibińska, E; Sowińska-Pik, V; Trznadel, K | 1 |
Henderson, IS; Jones, MC; McElduff, N; Pflanz, S | 1 |
Gerhardt, RE; Glickman, JD; Hugo, JP; Koethe, JD; Ntoso, KA; Wolf, CJ | 1 |
Böttger, WM; Kaufmann, BG; van den Bergh, JP; van Riet, GJ; Verstappen, VM | 1 |
Boberg, U; Ekman, R; Hegbrant, J; Mårtensson, L; Thysell, H | 1 |
Santoro, A; Spongano, M; Zucchelli, P | 1 |
Hirasawa, Y; Suzuki, M | 1 |
Kikuchi, F; Kuno, T; Nagura, Y; Takahashi, S; Yanai, M | 1 |
Chauveau, P; Itakura, Y; Man, NK; Yamauchi, T | 1 |
Fujisawa, K; Kobayakawa, H; Maeda, K; Miwa, M; Morita, H; Nakai, S; Shinzato, T; Takai, I | 1 |
Perrone, B | 1 |
France, NC; Holland, PT; Wallace, MR | 1 |
Grote, J; Klehr, HU; Wehler, M | 1 |
Barata, JD; Bruges, M; Furstenau, C; Gomes, EM; Oliveira, C; Simões, J | 1 |
Bergstrom, J; Ivanovich, P; Kishimoto, T; Klinkmann, H; Levin, N; Maekawa, M; Tanaka, H | 1 |
Ksiazek, A; Solski, J; Słomka, M; Wawrzycki, S; Załuska, W | 1 |
Fox, SD; Henderson, LW | 1 |
Maestro, J; Martin Mateo, MC | 1 |
Baldin, C; Calabrese, G; Gonella, M; Mazzotta, A; Pratesi, G; Vagelli, G | 1 |
Hörl, WH; Riegel, W | 1 |
Aronne, O; Cavicchioni, C; Ceriati, F; Pennisi, M; Proietti, R; Tebala, GD | 1 |
Quellhorst, E | 1 |
Janssen, MJ; ter Wee, PM; van Boven, WP; van der Kuy, A | 1 |
Sigler, MH; Skutches, CL | 1 |
Franek, E; Kokot, F; Rudka, R; Wiecek, A | 1 |
Bostan, M; Erem, C; Komsuoğlu, B; Kulan, K; Mocan, Z; Tuncer, C | 1 |
Dhakal, MP; Kallay, MC; Talley, TE | 1 |
Franson, KL; Kuk, JM; Lau, AH | 1 |
Campbell, M; Cody, J; Daly, C; Donaldson, C; Fitzhugh, K; Grant, A; Khan, I; Lawrence, P; MacLeod, A; Montague, G; Ritchie, C; Vale, L; Wallace, S | 1 |
Atti, M; Casiraghi, F; Gaspari, F; Imberti, B; Martina, G; Minetti, L; Noris, M; Remuzzi, G; Roccatello, D; Todeschini, M | 1 |
Alderman, JM; Meyer-Stout, PJ; Stamatakis, MK | 1 |
Amore, A; Coppo, R | 1 |
Böttger, WM; Gelens, MA; Kaufmann, BG; Klaassen, HA; van den Bergh, JP; Verstappen, VM | 1 |
Akçiçek, F; Kocaoğlu, S; Ozyer, A; Yalçin, A | 1 |
Llach, F; Yudd, M | 1 |
Chen, JS; Chen, PY; Chen, WY; Chung Wu, D; Huang, CL; Huang, JW; Hung, KY; Kan, YT; Lee, SH; Leu, LJ; Yang, CS | 1 |
d'Almeida Filho , EJ; da Cruz, EA; Hoette, M; Keen, LN; Lugon, JR; Ruzany, F | 1 |
Belgrade, M | 1 |
Bassilios, N; Deray, G; Khoury, N; Launay-Vacher, V; Rondeau, E; Sraer, JD | 1 |
Dennis, VW; Fatica, RA | 1 |
Aguila, E; Farber, HW; Jones, H | 1 |
Malluche, HH; Mawad, H | 1 |
Blumberg, A; Marti, HR | 1 |
Berkenstadt, Y; Berlyne, GM; Giat, Y; Shainkin, R | 1 |
Egan, JD; Wells, IC | 1 |
Boon, NA; Laker, MF; Mansell, MA; Nunan, TO; Wing, AJ | 1 |
Arfaania, D; Harris, PD; Miller, FN; Nolph, KD; Rubin, J; Wiegman, DL | 1 |
Tamaki, M | 1 |
Ash, KO; Nielsen, LG; Thor, E | 1 |
Lewis, EJ; Roberts, JL; Tolchin, N | 1 |
Barnes, RV; Easterling, RE; Port, FK | 1 |
Aizawa, Y; Hirasawa, Y; Ohmori, T; Shibata, A | 1 |
Mahony, JF; Savdie, E; Stewart, JH | 1 |
Emmanouel, DS; Jaspan, JB; Katz, AI; Kuku, SF; Rubenstein, AH; Zeidler, A | 1 |
Bembridge, JL; Jones, JG; Sapsford, DJ; Turney, JH | 1 |
Wanic-Kossowska, M | 1 |
Orłowski, A; Szepietowski, T | 1 |
Yamagami, S | 1 |
Kostkina, MI; Kulikova, AI; Shostka, GD; T'iagi, S; Vitenberg, AG | 1 |
Hirabayashi, M; Kunishige, H; Nakanishi, T; Nishimura, M; Takahashi, H; Tsuji, Y; Yasui, A; Yoshimura, M | 1 |
Anderson, J; Briefel, G; Jones, JM; McGuire, M; Ryu, JH; Yun, YP | 1 |
Shostka, GD; T'iagi, S | 1 |
Ando, K; Ando, Y; Sekiguchi, H | 1 |
Dohi, Y; Kanagawa, S; Yosikawa, Y | 1 |
Bhaskar, S; Gurudev, KC; Mani, MK; Pathak, V; Prabhakar, KS; Prakash, KC | 1 |
Benazzi, E; Civati, G; Guastoni, C; Minetti, L; Perego, A; Perrino, ML; Teatini, U | 1 |
Dobos, E; Sztriha, L; Túri, S | 1 |
Harmon, WE | 1 |
Búzás, E; Gál, G; Novák, Z; Salgó, L | 1 |
Grzegorzewska, AE; Uchman, G | 1 |
Cleveland, MB; Emmett, M; Kirkpatrick, WG; Nolan, CR; Schmitt, GW; Sirmon, MD | 1 |
Holechek, MJ | 1 |
Kozlov, VV; Kulikova, AI; Rumiantsev, ASh; Shostka, GD; Smirnov, AV; T'iagi, S | 1 |
Dalal, S; Daugirdas, JT; Gupta, DK; Ing, TS; Kar, PM; Yu, AW | 1 |
Butzin, CA; Califano, JR; Nolan, CR | 1 |
Chauveau, P; Kuno, T; Man, NK; Naret, C; Poignet, JL; Takahashi, S | 1 |
Baz, M; Crevat, AD; Elsen, R; Monti, JP; Murisasco, A; Sarrazin, MY | 1 |
Krämer, BK; Müller, GA; Ress, KM; Risler, T; Ulshöfer, TM | 1 |
De Backer, WA; De Broe, ME; Heyrman, RM; Van Waeleghem, JP | 1 |
Barbacini, S; Biasioli, S; Bragantini, L; Brendolan, A; Chiaramonte, S; Dell'Aquila, R; Feriani, M; La Greca, G; Milan, M; Ronco, C | 1 |
Belardi, P; Beltrame, G; Boero, R; Bonello, F; Guarena, C; Maffei, S; Piccoli, G; Quarello, F; Scalzo, B | 1 |
Diskin, CJ; Thomas, CE; Zellner, CP | 1 |
Ayus, JC; Krothapalli, RK | 1 |
Abitbol, C; Goldberg, R; Hsia, SL; Monkus, E; Novak, M; Strauss, J; Zilleruelo, G | 1 |
Chuĭkin, NA; Kukharchuk, VV; Kutsenko, AI; Mal'ginov, SV; Zaruba, AIu | 1 |
Diamond, SM; Henrich, WL; Pitcher, WD | 1 |
Emmett, M; Fordtran, JS; Mai, ML; Santa Ana, CA; Schiller, L; Sheikh, MS | 1 |
Emmett, M; Fordtran, JS; Maguire, JA; Nicar, MJ; Santa Ana, CA; Schiller, LR; Sheikh, MS | 1 |
Kobayakawa, H; Maeda, K; Shinzato, T | 1 |
Anderson, SA; Brater, DC; Brown-Cartwright, D; Chen, A; Jacob, GB; Toto, RD | 1 |
Anderson, SA; Brater, DC; Brown-Cartwright, D; Toto, RD | 1 |
Bergström, J; Danielsson, A; Gutierrez, A; Hultman, E | 1 |
Krämer, BK; Ress, KM; Risler, T; Ulshöfer, TM | 1 |
Arnold, D; Cardoso, M; Léveillé, M; Prud'Homme, M; Shoubridge, E; St-Louis, G; Vinay, P | 1 |
Kozlov, VV; Riabov, SI; Shostka, GD; Spiridonov, VN; Vasil'ev, AN | 1 |
Aguilera, D; Diab, N; Faivre, JM | 1 |
Harding, GB; Ward, RA; Wathen, RL; Williams, TE | 1 |
Cardoso, M; Courteau, M; Gougoux, A; Lapierre, L; Levelillee, M; Prud'homme, M; Rengel, M; Tejedor, A; Vinay, P; Vinet, B | 1 |
Armstrong, MK; Daugirdas, JT; Hayashi, JA; Ing, TS; Nawab, ZM; Weissberger, LE | 1 |
Bertulla, A; Cavatorta, F; Gentile, A; Queirolo, C; Rosselli, P; Vagge, R | 1 |
Bahner, U; Burghardt, W; Heidland, A; Kasper, H; Keller, F; Kortmann, B; Scheppach, W; Teschner, M | 1 |
Huttunen, KR; Ikäheimo, MJ; Linnaluoto, MK; Takkunen, JT | 1 |
Shaldon, S | 1 |
Antona, JM; Arrobas, M; Caravaca, F; Cubero, JJ; Pizarro, JL; Sanchez, E | 1 |
Jahn, H; Schmitt, R; Schohn, D | 1 |
Brignon, P; Faller, B; Marichal, JF; Straub, P; Wagner, D | 1 |
Köcher, P; Opatrný, K; Racek, J; Veselá, E | 1 |
Eber, M; Hauptmann, G; Jahn, HA; Schohn, DC | 1 |
André, JL; Brocard, O; Pierson, M | 1 |
Brezin, JH; Chinitz, JL; Schwartz, AB | 1 |
Issautier, R; Mion, C; Mourad, G | 1 |
Belber, A; Dennenberg, BS; Deuter, G; Krishna, GG; Narins, RG; Spann, JF; Stom, MC | 1 |
Bommer, J; Malluche, H; Ritz, E | 1 |
Hampl, H; Kessel, M; Schäfer, GE | 1 |
Arakawa, M; Gejyo, F; Igarashi, H; Kioi, S | 1 |
Dörp, E; Falkenhagen, D; Schmitt, E; Wüstenberg, PW | 1 |
Gennari, FJ | 1 |
Garbus, SB; Gonzalez, FM; Holbert, RD; Pearson, JE | 1 |
Gault, MH | 1 |
Micklus, MJ; Stein, IM | 1 |
Grantham, JJ; Irwin, RL; Qualizza, PB; Tucker, DR; Whittier, FC | 1 |
Coburn, JW; Massry, SG; Rosenbaum, BJ; Shinaberger, JH | 1 |
Balsan, S; Bourdeau, AM; Broyer, M; Sachs, C | 1 |
Eliahou, HE; Feng, PH; Iaina, A; Reisin, E; Weinberg, U | 1 |
Kluthe, R; Oechslen, D; Weingard, D | 1 |
Earnest, DL; Ingram, RH; Macon, EJ; Sadler, JH | 1 |
Biagini, M; Cioni, L; Giovannetti, S | 1 |
Whitefield, JB | 1 |
26 review(s) available for phenyl acetate and Chronic Kidney Failure
Article | Year |
---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.
Topics: Acetates; Bone Diseases; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Renal Dialysis; Sevelamer | 2016 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.
Topics: Acetates; Algorithms; Bone Density Conservation Agents; Calcitriol; Calcium; Calcium Compounds; Calcium Metabolism Disorders; Calcium, Dietary; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis Solutions; Ergocalciferols; Homeostasis; Humans; Intestinal Absorption; Kidney Failure, Chronic; Models, Biological; Phosphorus; Practice Guidelines as Topic; Reference Values; Renal Dialysis; Research Design; Ultrafiltration | 2010 |
The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Clinical Trials as Topic; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Pharmacology, efficacy and safety of oral phosphate binders.
Topics: Acetates; Animals; Calcium Compounds; Chelating Agents; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Intestinal Absorption; Kidney Failure, Chronic; Kidney Tubules, Proximal; Lanthanum; Parathyroid Hormone; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2011 |
Phosphate binder usage in kidney failure patients.
Topics: Acetates; Aluminum Compounds; Calcium Carbonate; Calcium Compounds; Clinical Trials as Topic; Epoxy Compounds; Humans; Iron Compounds; Ketoglutaric Acids; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Calcium salts in the treatment of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Drug Evaluation; Epoxy Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Phosphate-Binding Proteins; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; Treatment Outcome | 2003 |
Lithium acetate therapy in a maintenance hemodialysis patient.
Topics: Acetates; Antidepressive Agents; Depressive Disorder, Major; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 2004 |
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis: results of the CARE study.
Topics: Acetates; Calcium; Calcium Compounds; Double-Blind Method; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis | 2004 |
Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review.
Topics: Acetates; Adolescent; Adult; Aged; Amyloidosis; beta 2-Microglobulin; Blood Pressure; Child; Child, Preschool; Female; Hemodiafiltration; Hemodialysis Solutions; Hemofiltration; Humans; Hypotension; Kidney Failure, Chronic; Male; Middle Aged; Quality of Life; Randomized Controlled Trials as Topic; Renal Dialysis; Treatment Outcome | 2005 |
Treatment of hyperphosphatemia in patients with chronic kidney disease on maintenance hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Calcinosis; Calcium Compounds; Coronary Vessels; Disease Progression; Dose-Response Relationship, Drug; Epoxy Compounds; Humans; Kidney Failure, Chronic; Phosphates; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer; United States | 2005 |
Phosphate binders and management of hyperphosphataemia in end-stage renal disease.
Topics: Acetates; Aluminum Compounds; Bone Diseases, Metabolic; Calcinosis; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Central Nervous System Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Ferric Compounds; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus, Dietary; Polyamines; Renal Dialysis; Sevelamer | 2006 |
Factors affecting blood pressure in hemodialysis.
Topics: Acetates; Adult; Aged; Bicarbonates; Blood; Blood Pressure; Cardiovascular System; Carotid Sinus; Hemodynamics; Humans; Hypotension; Kidney Failure, Chronic; Middle Aged; Norepinephrine; Pressoreceptors; Renal Dialysis; Sodium; Ultrafiltration | 1982 |
Acetate-free biofiltration: state of the art.
Topics: Acetates; Acidosis; Bicarbonates; Biocompatible Materials; Hemodiafiltration; Hemodialysis Solutions; Humans; Inflammation; Kidney Failure, Chronic; Sodium | 1994 |
Cardiac depressant factors in renal disease.
Topics: Acetates; Animals; Cardiomyopathies; Heart; Humans; Ions; Kidney Diseases; Kidney Failure, Chronic; Multiple Organ Failure; Myocardium; Parathyroid Hormone; Receptors, Adrenergic, beta; Renal Dialysis; Uremia | 1993 |
Effectiveness and efficiency of methods of dialysis therapy for end-stage renal disease: systematic reviews.
Topics: Acetates; Bicarbonates; Buffers; Cellulose; Costs and Cost Analysis; Dialysis Solutions; Efficiency; Humans; Kidney Failure, Chronic; Membranes, Artificial; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Randomized Controlled Trials as Topic; Renal Dialysis; Time Factors | 1998 |
Nitric oxide production with PMMA membrane.
Topics: Acetates; Animals; Apoptosis; Bicarbonates; Biocompatible Materials; Cells, Cultured; Cellulose; Cytokines; DNA Damage; Endothelium, Vascular; Enzyme Induction; Hemodialysis Solutions; Humans; Hypotension; Kidney Failure, Chronic; Membranes, Artificial; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidation-Reduction; Polymethyl Methacrylate; Renal Dialysis; Sulfhydryl Compounds; Vasodilation; Zinc Fingers | 1999 |
Current medical management of secondary hyperparathyroidism.
Topics: Acetates; Administration, Oral; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Ethanol; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Intestinal Absorption; Kidney Failure, Chronic; Magnesium Compounds; Parathyroid Hormone; Parathyroidectomy; Phosphates; Phosphorus, Dietary | 2000 |
Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders.
Topics: Acetates; Antacids; Calcinosis; Calcium; Calcium Compounds; Coronary Artery Disease; Humans; Kidney; Kidney Failure, Chronic; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors | 2002 |
Management of hyperphosphataemia of chronic kidney disease: lessons from the past and future directions.
Topics: Acetates; Calcium Compounds; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders | 2002 |
[Comparative study of acetate and bicarbonate hemodialysis in children with chronic uremia].
Topics: Acetates; Adolescent; Carbon Dioxide; Child; Humans; Hypotension; Kidney Failure, Chronic; Renal Dialysis; Uremia | 1991 |
[The effect of hemodialysis, using acetate and bicarbonate, on erythrocyte deformability].
Topics: Acetates; Bicarbonates; Erythrocyte Deformability; Erythrocytes; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Uremia | 1991 |
Effect of bicarbonate administration on cardiac function.
Topics: Acetates; Acid-Base Equilibrium; Animals; Bicarbonates; Heart; Heart Failure; Humans; Hypotension; Kidney Failure, Chronic; Renal Dialysis | 1989 |
Acetate metabolism during hemodialysis: metabolic considerations.
Topics: Acetates; Bicarbonates; Humans; Kidney Failure, Chronic; Renal Dialysis | 1987 |
Bicarbonate dialysis--so what?
Topics: Acetates; Acid-Base Equilibrium; Bicarbonates; Bone and Bones; Humans; Hyperlipidemias; Hypotension; Kidney Failure, Chronic; Minerals; Renal Dialysis; Vasodilation | 1985 |
52 trial(s) available for phenyl acetate and Chronic Kidney Failure
Article | Year |
---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.
Topics: Acetates; Acid-Base Equilibrium; Adult; Aged; Bicarbonates; Cross-Over Studies; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis; Single-Blind Method | 2017 |
[Clinical and laboratory evaluation of the efficiency of chronic hemodialysis treatment using acidosuccinate in patients with terminal renal failure].
Topics: Acetates; Biomarkers; Cross-Over Studies; Dialysis Solutions; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Quality of Life; Renal Dialysis; Succinic Acid; Treatment Outcome | 2013 |
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers; Bone and Bones; Calcium Compounds; Chelating Agents; Enzyme-Linked Immunosorbent Assay; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Kidney Function Tests; Magnesium; Male; Middle Aged; Parathyroid Hormone; Polyamines; Prognosis; Renal Dialysis; Risk Factors; Sevelamer; Young Adult | 2013 |
A randomized controlled study on the effects of acetate-free biofiltration on organic anions and acid-base balance in hemodialysis patients.
Topics: Acetates; Acid-Base Equilibrium; Acidosis; Age Factors; Aged; Aged, 80 and over; Anions; Bicarbonates; Cross-Over Studies; Dialysis Solutions; Female; Hemodiafiltration; Humans; Kidney Failure, Chronic; Male; Middle Aged; Reference Values; Renal Dialysis; Risk Assessment; Single-Blind Method; Survival Rate; Treatment Outcome | 2015 |
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
Topics: Acetates; Aged; Calcium; Calcium Compounds; Chelating Agents; Female; Ferric Compounds; Humans; Hyperphosphatemia; Inflammation Mediators; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2015 |
Acute effect of citrate bath on postdialysis alkalaemia.
Topics: Acetates; Acid-Base Imbalance; Acidosis; Adult; Bicarbonates; Blood Gas Analysis; Citrates; Cross-Over Studies; Electrolytes; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Prospective Studies | 2015 |
Therapeutic Effect of Montelukast for Treatment of Uremic Pruritus in Hemodialysis Patients.
Topics: Acetates; Adult; C-Reactive Protein; Cyclopropanes; Drug Monitoring; Female; Humans; Kidney Failure, Chronic; Leukotriene Antagonists; Male; Middle Aged; Pruritus; Quinolines; Renal Dialysis; Sulfides; Treatment Outcome; Uremia | 2017 |
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
Topics: Acetates; Adult; Aged; Calcium Compounds; Chelating Agents; Drug Tolerance; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Polyamines; Sevelamer | 2009 |
[Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance].
Topics: Acetates; Adult; Aged; Aged, 80 and over; Bicarbonates; Body Weight; Chlorides; Female; Hemodiafiltration; Hemodialysis Solutions; Hemodynamics; Humans; Hypotension; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Young Adult | 2009 |
Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cost-Benefit Analysis; Drug Costs; Follow-Up Studies; Health Care Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Medicaid; Medicare; Phosphates; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome; United States | 2009 |
Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
Topics: Acetates; Adult; Analysis of Variance; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcitriol; Calcium; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Dialysis Solutions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Sevelamer; Tomography, X-Ray Computed | 2011 |
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2010 |
Biocompatibility of dialysis fluid for online HDF.
Topics: Acetates; Adult; Aged; Biocompatible Materials; Blood Glucose; C-Reactive Protein; Cross-Over Studies; Dialysis Solutions; Female; Hemodiafiltration; Humans; Hydrogen-Ion Concentration; Interleukin-6; Kidney Failure, Chronic; Male; Materials Testing; Middle Aged; Water-Electrolyte Balance | 2011 |
Preferred dialysis fluid for the high-performance membrane.
Topics: Acetates; Acidosis; Aged; alpha-2-HS-Glycoprotein; Bicarbonates; Biocompatible Materials; C-Reactive Protein; Dialysis Solutions; Electrolytes; Female; Glucose; Humans; Inflammation; Interleukin-6; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Molecular Weight; Polymers; Renal Dialysis; Sulfones | 2011 |
A preference study: calcium acetate tablets versus gelcaps in hemodialysis patients.
Topics: Acetates; Calcium Compounds; Female; Gels; Humans; Kidney Failure, Chronic; Male; Middle Aged; Patient Satisfaction; Phosphates; Renal Dialysis; Tablets; Treatment Refusal | 2002 |
Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: a comparison with calcium acetate.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Calcium; Calcium Compounds; Epoxy Compounds; Female; Humans; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Effect of acetate and bicarbonate dialysate on whole body bioimpedance (BIS) and segmental (thoracic) bioimpedance in hemodialysed (HD) patients.
Topics: Acetates; Aged; Bicarbonates; Body Fluid Compartments; Body Fluids; Dialysis Solutions; Electric Impedance; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Plethysmography, Impedance; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Thorax; Ultrafiltration | 2002 |
Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer.
Topics: Acetates; Aortic Valve; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Heart Valve Diseases; Humans; Kidney Failure, Chronic; Mitral Valve; Multivariate Analysis; Renal Dialysis; Tomography, X-Ray Computed | 2004 |
Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
Topics: Acetates; Adolescent; Calcitriol; Calcium; Calcium Carbonate; Calcium Channel Agonists; Calcium Compounds; Child; Child, Preschool; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphates; Renal Dialysis | 2005 |
Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.
Topics: Acetates; Calcinosis; Calcium; Calcium Carbonate; Calcium Compounds; Coronary Vessels; Diabetes Mellitus; Female; Humans; Hypoparathyroidism; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2006 |
A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Analysis of Variance; Biomarkers; Bone Remodeling; Calcium; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Research Design; Sevelamer; Treatment Outcome | 2006 |
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Topics: Acetates; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Reproducibility of Results; Sevelamer; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.
Topics: Acetates; Aged; Calcium Compounds; Chelating Agents; Female; Hemodialysis Solutions; Hospitalization; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer | 2008 |
Comparison of the hemodynamic response to hemodialysis with acetate or bicarbonate.
Topics: Acetates; Adult; Bicarbonates; Blood Pressure; Cardiac Output; Clinical Trials as Topic; Double-Blind Method; Female; Heart; Heart Rate; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Dialysis; Renin; Stroke Volume; Vascular Resistance | 1983 |
Reducing patient morbidity from high-efficiency hemodialysis: a double-blind crossover trial.
Topics: Acetates; Acetic Acid; Adolescent; Adult; Bicarbonates; Blood Pressure; Fatigue; Headache; Humans; Kidney Failure, Chronic; Muscle Cramp; Renal Dialysis; Sodium Bicarbonate; Vomiting | 1983 |
Gas exchange during dialysis. Contrasting mechanisms contributing to comparable alterations with acetate and bicarbonate buffers.
Topics: Acetates; Bicarbonates; Buffers; Carbon Dioxide; Clinical Trials as Topic; Double-Blind Method; Humans; Hydrogen-Ion Concentration; Hypoxia; Kidney Failure, Chronic; Middle Aged; Pulmonary Gas Exchange; Renal Dialysis; Time Factors | 1984 |
[Hemodynamics during hemodialysis, hemofiltration and hemodiafiltration using bicarbonate vs acetate buffers].
Topics: Acetates; Adult; Aged; Bicarbonates; Blood; Buffers; Female; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Ultrafiltration | 1984 |
[Effect of bicarbonate and acetate dialysates on hemodialysis in chronic renal failure].
Topics: Acetates; Adult; Bicarbonates; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1981 |
A double-blind controlled trial of acetate versus bicarbonate dialysate.
Topics: Acetates; Bicarbonates; Blood Gas Analysis; Clinical Trials as Topic; Creatinine; Double-Blind Method; Electrolytes; Humans; Kidney Failure, Chronic; Muscle Cramp; Renal Dialysis | 1980 |
Serum levels of acetate and TCA cycle intermediates during hemodialysis in relation to symptoms.
Topics: Acetates; Adult; Citrates; Citric Acid; Citric Acid Cycle; Female; Humans; Isocitrates; Ketoglutaric Acids; Kidney Failure, Chronic; Lactates; Lactic Acid; Male; Middle Aged; Pyruvates; Pyruvic Acid; Renal Dialysis | 1982 |
Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis.
Topics: Acetates; Acetic Acid; Adult; Aged; Calcium; Calcium Carbonate; Cross-Over Studies; Drug Tolerance; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Compliance; Phosphates; Renal Dialysis | 1994 |
Comparison of three formulations of calcium acetate tablets to evaluate tolerance and control of hyperphosphatemia in patients with chronic renal failure.
Topics: Acetates; Acetic Acid; Aged; Chemistry, Pharmaceutical; Cross-Over Studies; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Pilot Projects; Tablets | 1994 |
Clinical advantages of acetate-free biofiltration.
Topics: Acetates; Acidosis; Adult; beta 2-Microglobulin; Bicarbonates; Blood Urea Nitrogen; Cardiovascular Diseases; Energy Intake; Female; Gastrointestinal Diseases; Hemodiafiltration; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pain; Phosphates; Renal Dialysis | 1994 |
Dialysis-induced hypoxaemia.
Topics: Acetates; Carbon Dioxide; Dialysis Solutions; Equipment and Supplies; Humans; Hypoxia; Kidney Failure, Chronic; Oxygen; Renal Dialysis; Time Factors | 1993 |
Cardiovascular response during hemodialysis and hemofiltration: thermal, membrane, and catecholamine influences.
Topics: Acetates; Acrylic Resins; Acrylonitrile; Aged; Aged, 80 and over; Autonomic Nervous System; Blood Urea Nitrogen; Body Fluids; Body Temperature; Cations; Diabetic Nephropathies; Diabetic Neuropathies; Hemodialysis Solutions; Hemodynamics; Hemofiltration; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Norepinephrine; Renal Dialysis; Weight Loss | 1993 |
Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Topics: Acetates; Acetic Acid; Aluminum Hydroxide; Calcium Carbonate; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Patient Compliance; Phosphates; Prospective Studies; Renal Dialysis; Time Factors | 1996 |
Phosphate-binding capacities of calcium and aluminum formulations.
Topics: Acetates; Administration, Oral; Adult; Aluminum Compounds; Calcium Carbonate; Calcium Phosphates; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Monitoring; Female; Gels; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Phosphates; Suspensions; Tablets | 1998 |
Effect of acetate, bicarbonate dialysis, and acetate-free biofiltration on nitric oxide synthesis: implications for dialysis hypotension.
Topics: Acetates; Adult; Aged; Bicarbonates; Cells, Cultured; Cross-Over Studies; Endothelium, Vascular; Female; Hemodiafiltration; Hemodialysis Solutions; Hemodynamics; Humans; Hypotension; Interleukin-1; Kidney Failure, Chronic; Male; Middle Aged; Nitric Oxide; Pilot Projects; Renal Dialysis; Umbilical Veins | 1998 |
Efficacy and tolerance of three different calcium acetate formulations in hemodialysis patients.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Calcium; Calcium Compounds; Chemistry, Pharmaceutical; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Female; Gastrointestinal Diseases; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Renal Dialysis; Tablets, Enteric-Coated | 1999 |
Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients.
Topics: Acetates; Adult; Analysis of Variance; Antacids; Calcium Carbonate; Cross-Over Studies; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus Metabolism Disorders; Renal Dialysis | 2000 |
Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2-microglobulin plasma levels.
Topics: Acetates; Acetic Acid; Adult; beta 2-Microglobulin; Female; Humans; Interleukin-1; Interleukin-6; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 1991 |
Short term study on relative merits of acetate and bicarbonate dialysis.
Topics: Acetates; Adolescent; Adult; Bicarbonates; Double-Blind Method; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1991 |
High-flux acetate haemodialysis: a single-centre experience.
Topics: Acetates; beta 2-Microglobulin; Cholesterol; Cholesterol, HDL; Hemodynamics; Humans; Hypotension; Interleukin-1; Inulin; Kidney Failure, Chronic; Renal Dialysis; Triglycerides | 1991 |
Calcium acetate control of serum phosphorus in hemodialysis patients.
Topics: Acetates; Acetic Acid; Adult; Aged; Aluminum; Calcium; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1991 |
L-lactate high-efficiency hemodialysis: hemodynamics, blood gas changes, potassium/phosphorus, and symptoms.
Topics: Acetates; Bicarbonates; Blood Gas Analysis; Blood Pressure; Dialysis Solutions; Double-Blind Method; Hemodynamics; Humans; Kidney Failure, Chronic; Lactates; Lactic Acid; Male; Middle Aged; Phosphorus; Potassium; Renal Dialysis | 1990 |
Influence of calcium acetate or calcium citrate on intestinal aluminum absorption.
Topics: Acetates; Acetic Acid; Adult; Aluminum; Aluminum Hydroxide; Citrates; Citric Acid; Contraindications; Drug Interactions; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Phosphates | 1990 |
Effect of dialysate composition on the lipid response to L-carnitine supplementation.
Topics: Acetates; Adolescent; Adult; Bicarbonates; Carnitine; Clinical Trials as Topic; Dialysis Solutions; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Lipids; Male; Renal Dialysis | 1989 |
Calcium acetate, an effective phosphorus binder in patients with renal failure.
Topics: Acetates; Acetic Acid; Adult; Calcium Carbonate; Female; Humans; Intestinal Absorption; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis | 1989 |
Influence of sodium dialysate variation on hemodynamic stability.
Topics: Acetates; Aged; Female; Heart Rate; Hemodynamics; Humans; Hypotension; Hypotension, Orthostatic; Kidney Failure, Chronic; Male; Middle Aged; Osmolar Concentration; Renal Dialysis; Sodium | 1988 |
Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes.
Topics: Acetates; Acid-Base Equilibrium; Bicarbonates; Blood Glucose; Electrolytes; Female; Glucose; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Renal Dialysis | 1987 |
Use of lactate as a base in hemodialysis.
Topics: Acetates; Acetic Acid; Acid-Base Equilibrium; Clinical Trials as Topic; Double-Blind Method; Humans; Kidney Failure, Chronic; Lactates; Lactic Acid; Male; Random Allocation; Renal Dialysis | 1987 |
171 other study(ies) available for phenyl acetate and Chronic Kidney Failure
Article | Year |
---|---|
Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapy.
Topics: Acetates; Antiviral Agents; Humans; Kidney Failure, Chronic; Quinazolines; Renal Replacement Therapy | 2021 |
Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.
Topics: Acetates; Aged, 80 and over; Calcium Compounds; Carcinoma, Renal Cell; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Humans; Indazoles; Kidney Failure, Chronic; Kidney Neoplasms; Male; Oxalates; Pancreatic Neoplasms; Pancrelipase; Protein Kinase Inhibitors; Pyrimidines; Renal Dialysis; Sulfonamides; Treatment Outcome | 2019 |
Effectiveness of montelukast for uremic pruritus in hemodialysis patients: A protocol for systematic review and meta-analysis.
Topics: Acetates; Clinical Protocols; Cyclopropanes; Humans; Kidney Failure, Chronic; Leukotriene Antagonists; Meta-Analysis as Topic; Pruritus; Quinolines; Renal Dialysis; Sulfides; Systematic Reviews as Topic | 2020 |
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study.
Topics: Acetates; Acrylic Resins; Aged; Dialysis Solutions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Hemodiafiltration; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pilot Projects | 2018 |
Comparison of the hemodynamic tolerance and the biological parameters of four acetate-free hemodialysis methods.
Topics: Acetates; Aged; Aged, 80 and over; Citric Acid; Cross-Over Studies; Dialysis Solutions; Female; Hemodiafiltration; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies | 2017 |
Phosphate binder choices used in ESRD patients.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Calcium Compounds; Chelating Agents; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Retrospective Studies; Sevelamer; Young Adult | 2016 |
Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients.
Topics: Acetates; Adult; Aged; Alkalosis; Arrhythmias, Cardiac; Bicarbonates; Buffers; Death, Sudden, Cardiac; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Renal Dialysis | 2019 |
Alkali delivery in chronic hemodialysis: Would more acetate be helpful?
Topics: Acetates; Alkalies; Buffers; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Renal Dialysis; Sodium Bicarbonate | 2019 |
Acetate metabolism, organic acid production, and the independent effects of bicarbonate and acetate as alkalinizing agents in dialysis bath solutions.
Topics: Acetates; Bicarbonates; Dialysis Solutions; Humans; Kidney Failure, Chronic; Renal Dialysis | 2019 |
Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia.
Topics: Acetates; Adenine; Animals; Aortic Diseases; Bone Morphogenetic Protein 2; Calcium; Calcium Compounds; Calcium-Binding Proteins; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Extracellular Matrix Proteins; Gene Expression Regulation; Hyperphosphatemia; Kidney Failure, Chronic; Magnesium; Male; Matrix Gla Protein; Parathyroid Hormone; Phosphates; Polyamines; Rats; Rats, Wistar; Sevelamer; SOX9 Transcription Factor; Time Factors; Uremia; Vascular Calcification | 2013 |
In vivo proton MR spectroscopy in uterine abscesses.
Topics: Abscess; Acetates; Aged; Escherichia coli; Female; Humans; Kidney Failure, Chronic; Magnetic Resonance Spectroscopy; Middle Aged; Pelvic Inflammatory Disease; Peptostreptococcus; Porphyromonas; Staphylococcus aureus; Succinic Acid; Uterus | 2013 |
Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Compounds; Female; Humans; Hyperphosphatemia; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Medicare Part D; Polyamines; Renal Dialysis; Sevelamer; Survival Rate; Treatment Outcome; United States | 2014 |
Reasons for phosphate binder discontinuation vary by binder type.
Topics: Acetates; Adult; Aged; Calcium Compounds; Female; Gastrointestinal Tract; Humans; Hypercalcemia; Hypophosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Medication Adherence; Middle Aged; Phosphates; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Treatment Outcome; United States | 2014 |
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome | 2014 |
A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats.
Topics: Acetates; Animals; Biomarkers; Bone and Bones; Bone Remodeling; Calcium Compounds; Diet; Disease Models, Animal; Kidney Failure, Chronic; Magnesium; Male; Phosphates; Phosphorus; Rats; Vascular Calcification | 2014 |
Cysteinyl 1 receptor antagonist montelukast, does not prevent peritoneal membrane damage in experimental chronic peritoneal dialysis model in rats.
Topics: Acetates; Animals; Cyclopropanes; Cytokines; Fibrosis; Kidney Failure, Chronic; Leukotriene Antagonists; Male; Membranes; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Quinolines; Rats; Rats, Wistar; Sulfides; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2014 |
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Topics: Acetates; Aged; C-Reactive Protein; Calcium Carbonate; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Cost-Benefit Analysis; Databases, Factual; Female; Humans; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Phosphates; Prospective Studies; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer; Stroke; Survival Analysis; Vitamin D | 2015 |
The use of phosphate binders: data from contributors to the European Practice Database.
Topics: Acetates; Aluminum Compounds; Analysis of Variance; Calcium Carbonate; Calcium Compounds; Chelating Agents; Cross-Sectional Studies; Databases, Factual; Dietetics; Drug Utilization; Europe; Health Care Surveys; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Lanthanum; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Sevelamer; Surveys and Questionnaires; Vitamin D | 2009 |
Assessment of bone mineral metabolism derangements by K/DOQI guidelines in haemodialysis patients at Rawalpindi.
Topics: Acetates; Adult; Aged; Bone and Bones; Bone Diseases, Metabolic; Calcium; Calcium Carbonate; Calcium Compounds; Female; Guideline Adherence; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pakistan; Parathyroid Hormone; Phosphates; Practice Guidelines as Topic; Renal Dialysis | 2009 |
Metabolic and hemodynamic advantages of an acetate-free citrate dialysate in a uremic case of congenital methylmalonic acidemia.
Topics: Acetates; Adult; Amino Acid Metabolism, Inborn Errors; Blood Pressure; Citrates; Female; Heart Rate; Hemodynamics; Humans; Kidney Failure, Chronic; Methylmalonic Acid; Renal Dialysis; Uremia; Vascular Resistance | 2009 |
Lanthanum carbonate provides control of phosphorus levels in patients new to phosphate binder therapy and patients changed from other phosphate binders.
Topics: Acetates; Aged; Aged, 80 and over; Calcium Carbonate; Calcium Compounds; Chelating Agents; Humans; Kidney Failure, Chronic; Lanthanum; Middle Aged; New York; Nutritional Status; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Serum Albumin; Sevelamer; Treatment Outcome | 2011 |
Effects of acetate-free haemodiafiltration (HDF) with endogenous reinfusion (HFR) on cardiac troponin levels.
Topics: Acetates; Aged; Bicarbonates; Biomarkers; Blood Pressure; Blood Volume; Buffers; Cardiovascular Diseases; Female; Heart Rate; Hemodiafiltration; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Survival Rate; Treatment Outcome; Troponin C | 2011 |
Stomach calcification revealed by gastrofibroscopy in a haemodialysis patient.
Topics: Acetates; Biopsy; Calcinosis; Calcium Compounds; Chelating Agents; Fiber Optic Technology; Gastroscopy; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Stomach Diseases; Vitamin D; Vitamins | 2010 |
[Acetate-free hemodialysis: what does it mean?].
Topics: Acetates; Bicarbonates; Hemodiafiltration; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Quality of Life; Renal Dialysis; Treatment Outcome | 2011 |
Hypophosphatemia in kidney transplant recipients: report of acute phosphate nephropathy as a complication of therapy.
Topics: Acetates; Administration, Oral; Aged; Biopsy; Calcium Compounds; Creatinine; Female; Humans; Hypophosphatemia; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Phosphates; Renal Insufficiency; Treatment Outcome | 2011 |
Calcium on trial: beyond a reasonable doubt?
Topics: Acetates; Calcium; Calcium Carbonate; Calcium Compounds; Humans; Hypercalcemia; Kidney Failure, Chronic; Renal Dialysis | 2003 |
[Vascular and tissue calcifications of hemodialysis patients].
Topics: Acetates; Adult; Aged; Argentina; Calcinosis; Calcium; Calcium Compounds; Calcium, Dietary; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic Nephropathies; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organ Specificity; Phosphorus; Radiography; Renal Dialysis; Vascular Diseases | 2003 |
[Metabolic effects of 4-chlortestosterone acetate in chronic nephropathies of the aged].
Topics: Acetates; Aged; Aged, 80 and over; Humans; Kidney Diseases; Kidney Failure, Chronic; Renal Insufficiency, Chronic; Testosterone | 1959 |
Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification.
Topics: Acetates; Calcium; Calcium Compounds; Coronary Artery Disease; Epoxy Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Gabapentin-induced hypoglycemia in a long-term peritoneal dialysis patient.
Topics: Acetates; Amines; C-Peptide; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Gluconeogenesis; Humans; Hypoglycemia; Hypotension; Insulin; Kidney Cortex; Kidney Failure, Chronic; Liver; Middle Aged; Pancreas; Parathyroidectomy; Peritoneal Dialysis; Postoperative Complications | 2003 |
A broad-based metabolic approach to study VLDL apoB100 metabolism in patients with ESRD and patients treated with peritoneal dialysis.
Topics: Acetates; Adult; Apolipoprotein B-100; Apolipoproteins B; Carbon Isotopes; Cholesterol, VLDL; Deuterium; Fatty Acids, Nonesterified; Female; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin; Kidney Failure, Chronic; Lipolysis; Male; Middle Aged; Palmitates; Peritoneal Dialysis; Valine | 2004 |
Calcium acetate-induced linear fixed drug eruption.
Topics: Acetates; Calcium Compounds; Diagnosis, Differential; Drug Eruptions; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2005 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |
Phosphate binders.
Topics: Acetates; Calcium Carbonate; Calcium Compounds; Humans; Kidney Failure, Chronic; Lanthanum; Phosphates; Polyamines; Sevelamer | 2006 |
Controversies in the management of hyperphosphatemia in patients with end-stage renal disease.
Topics: Acetates; Calcinosis; Calcium Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Conflict, Psychological; Disease Management; Humans; Kidney Failure, Chronic; Phosphates; Treatment Outcome; United States | 2006 |
Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
Topics: Acetates; Bicarbonates; Calcium; Calcium Carbonate; Calcium Compounds; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Humans; Hypophosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer | 2006 |
Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Topics: Acetates; Adult; Bicarbonates; Biomarkers; Blood Pressure; Blood Urea Nitrogen; Creatinine; Dialysis Solutions; Female; Follow-Up Studies; Humans; Hypotension; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Potassium; Renal Dialysis; Risk Factors; Serum Albumin; Sodium; Treatment Outcome | 2006 |
Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Topics: Acetates; Animals; Antioxidants; Apoptosis; Blood Urea Nitrogen; Collagen; Creatinine; Cyclopropanes; Glutathione; Interleukin-1beta; Interleukin-6; Kidney; Kidney Failure, Chronic; L-Lactate Dehydrogenase; Leukocytes; Leukotriene Antagonists; Lung; Male; Malondialdehyde; Membrane Proteins; Multiple Organ Failure; Quinolines; Random Allocation; Rats; Rats, Wistar; Receptors, Leukotriene; Sulfides; Tumor Necrosis Factor-alpha | 2007 |
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice.
Topics: Acetates; Calcium Compounds; Chelating Agents; Hemodialysis Solutions; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Nephrology; Polyamines; Practice Patterns, Physicians'; Renal Dialysis; Research Design; Sevelamer | 2008 |
[Clinical and analytical changes in hemodialysis without acetate].
Topics: Acetates; Adult; Aged; Aged, 80 and over; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 2007 |
Hemodialysis with base free dialysate.
Topics: Acetates; Bicarbonates; Buffers; Carbon Dioxide; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Kidney Failure, Chronic; Renal Dialysis; Sodium Bicarbonate; Systole | 1980 |
[Effects of improved levels of plasma bicarbonates in terminal renal failure].
Topics: Acetates; Acidosis; Adult; Aged; Bicarbonates; Humans; Kidney Failure, Chronic; Middle Aged; Sodium Bicarbonate | 1983 |
A new bedside hemodialysis monitor for both acetate and bicarbonate dialysis.
Topics: Acetates; Bicarbonates; Blood Urea Nitrogen; Creatinine; Dialysis Solutions; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Microcomputers; Uric Acid | 1983 |
Contribution of dialysate acetate to energy metabolism: metabolic implications.
Topics: Acetates; Adult; Aged; Carbon Dioxide; Carbon Radioisotopes; Energy Metabolism; Female; Homeostasis; Humans; Kidney Failure, Chronic; Male; Middle Aged; Oxidation-Reduction; Oxygen Consumption; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Solutions; Time Factors | 1983 |
Respiratory response of acetate dialysis and bicarbonate dialysis.
Topics: Acetates; Adult; Aged; Bicarbonates; Carbon Dioxide; Female; Humans; Hypoxia; Kidney Failure, Chronic; Male; Middle Aged; Pulmonary Gas Exchange; Renal Dialysis; Ventilation-Perfusion Ratio | 1983 |
Effect of dialysis on lipid metabolism in chronic renal failure - acetate versus bicarbonate.
Topics: Acetates; Adult; Apolipoprotein A-I; Apolipoproteins; Bicarbonates; Cholesterol; Cholesterol, HDL; Fatty Acids, Nonesterified; Female; Humans; Kidney Failure, Chronic; Lipids; Lipoproteins; Lipoproteins, HDL; Male; Middle Aged; Phospholipids; Renal Dialysis; Triglycerides | 1983 |
[Pathophysiologic aspects in the treatment of diabetic patients during acetate and bicarbonate dialysis].
Topics: Acetates; Adult; Bicarbonates; Carbon Dioxide; Diabetic Nephropathies; Hemodynamics; Humans; Kidney Failure, Chronic; Middle Aged; Oxygen; Renal Dialysis | 1984 |
Acid base values, hypoxemia in diabetic patients on acetate and bicarbonate dialysis.
Topics: Acetates; Acid-Base Equilibrium; Adult; Bicarbonates; Carbon Dioxide; Diabetic Nephropathies; Humans; Hypoxia; Kidney Failure, Chronic; Middle Aged; Oxygen; Renal Dialysis | 1984 |
Respiratory response and acid base balance during acetate (AD), bicarbonate (BD) and acetate + CO2 (ADCO2) dialysis.
Topics: Acetates; Acid-Base Equilibrium; Adult; Aged; Bicarbonates; Carbon Dioxide; Dialysis Solutions; Female; Humans; Hypoxia; Kidney Failure, Chronic; Male; Middle Aged; Oxygen; Renal Dialysis | 1983 |
[Acetate dialysate: responsible for decrease in ultrafiltration in continuous ambulatory peritoneal dialysis].
Topics: Acetates; Adolescent; Adult; Aged; Buffers; Female; Humans; Hypotonic Solutions; Isotonic Solutions; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Ultrafiltration | 1984 |
[Plasma acetate and bicarbonate kinetics and intolerance to acetate during and after renal dialysis].
Topics: Acetates; Bicarbonates; Hemodynamics; Humans; Kidney Failure, Chronic; Kinetics; Renal Dialysis; Vomiting | 1984 |
Hemodynamic changes during acetate and bicarbonate hemodialysis.
Topics: Acetates; Adult; Aged; Bicarbonates; Blood Pressure; Cardiac Output; Double-Blind Method; Echocardiography; Female; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction; Renal Dialysis; Stroke Volume; Vascular Resistance | 1984 |
Relative contribution of intrinsic lung dysfunction and hypoventilation to hypoxemia during hemodialysis.
Topics: Acetates; Adult; Aged; Bicarbonates; Cellulose; Female; Hemoglobins; Humans; Hypoventilation; Hypoxia; Kidney Failure, Chronic; Leukocyte Count; Lung; Male; Membranes, Artificial; Middle Aged; Pulmonary Diffusing Capacity; Pulmonary Gas Exchange; Renal Dialysis; Respiratory Function Tests | 1984 |
Peracetic acid for reuse of hemodialyzers clinical studies.
Topics: Acetates; Disinfection; Formaldehyde; Humans; Kidney Failure, Chronic; Peracetic Acid; Renal Dialysis; Risk; Sterilization | 1984 |
Observations on inadequate buffer concentration in peritoneal dialysis solutions for CCPD.
Topics: Acetates; Adolescent; Adult; Aged; Blood Chemical Analysis; Buffers; Female; Hematocrit; Humans; Kidney Failure, Chronic; Lactates; Lactic Acid; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory | 1983 |
[Echocardiographic studies on left ventricular function in patients undergoing hemodialysis--comparison between acetate and bicarbonate dialysates].
Topics: Acetates; Adult; Aged; Bicarbonates; Echocardiography; Female; Heart; Heart Ventricles; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1983 |
Mechanisms producing hypoxemia during hemodialysis.
Topics: Acetates; Adult; Humans; Hypoventilation; Hypoxia; Kidney Failure, Chronic; Middle Aged; Oxygen; Pulmonary Gas Exchange; Renal Dialysis; Time Factors | 1984 |
Acid-base changes and acetate metabolism during routine and high-efficiency hemodialysis in children.
Topics: Acetates; Acidosis; Adolescent; Bicarbonates; Carbon Dioxide; Child; Fatty Acids; Female; Homeostasis; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Male; Renal Dialysis; Time Factors | 1981 |
Hypoxemia during hemodialysis.
Topics: Acetates; Bicarbonates; Carbon Dioxide; Humans; Hydrogen-Ion Concentration; Hypoxia; Kidney Failure, Chronic; Leukopenia; Neutropenia; Oxygen Consumption; Pulmonary Alveoli; Renal Dialysis; Respiration | 1982 |
The relative effect of leukopenia and dialysate composition on the dialysis-associated hypoxemia.
Topics: Acetates; Bicarbonates; Carbon Dioxide; Humans; Hypoxia; Kidney Failure, Chronic; Leukopenia; Membranes, Artificial; Renal Dialysis; Time Factors; Vomiting | 1980 |
Prevention of dialysis induced hypoxemia with bicarbonate dialysate--role of acetate in etiology.
Topics: Acetates; Adult; Aged; Bicarbonates; Carbon Dioxide; Humans; Hypoxia; Kidney Failure, Chronic; Middle Aged; Osmolar Concentration; Oxygen; Renal Dialysis | 1980 |
Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
Topics: Acetates; Acrylic Resins; Adolescent; Adult; Blood; Cellulose; Complement Activation; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Leukopenia; Membranes, Artificial; Middle Aged; Oxygen; Renal Dialysis; Time Factors; Ultrafiltration | 1983 |
No relationship between acetate and hypotension in a standard dialysis schedule.
Topics: Acetates; Aged; Bicarbonates; Female; Humans; Hypotension; Kidney Failure, Chronic; Kidneys, Artificial; Kinetics; Male; Middle Aged; Renal Dialysis | 1983 |
The use of bicarbonate-buffered dialyzing solution for chronic hemodialysis patients with established acetate buffer intolerance.
Topics: Acetates; Bicarbonates; Buffers; Drug Tolerance; Headache; Humans; Kidney Failure, Chronic; Nausea; Renal Dialysis | 1981 |
Infection of the abdominal cavity and chronic peritoneal dialysis.
Topics: Acetates; Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Catheters, Indwelling; Escherichia coli Infections; Female; Humans; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis; Peritonitis; Proteus Infections; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections | 1981 |
Lymphocyte and granulocyte function in zinc-treated and zinc-deficient hemodialysis patients.
Topics: Acetates; Acetic Acid; Cell Movement; Chemotaxis, Leukocyte; Granulocytes; Humans; Kidney Failure, Chronic; Lymphocyte Activation; Male; Middle Aged; Renal Dialysis; Zinc | 1982 |
The effect of hyperacetatemia on cardiac output during regular hemodialysis.
Topics: Acetates; Adult; Cardiac Output; Cardiography, Impedance; Humans; Kidney Failure, Chronic; Renal Dialysis | 1982 |
Acid-base physiology in uremia.
Topics: Acetates; Acetic Acid; Acid-Base Imbalance; Bicarbonates; Bone and Bones; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Minerals; Parathyroid Hormone; Uremia | 1982 |
Pathogenesis of dialysis-induced hypoxemia.
Topics: Acetates; Acetic Acid; Bicarbonates; Blood Gas Analysis; Forced Expiratory Flow Rates; Humans; Hypoxia; Kidney Failure, Chronic; Renal Dialysis | 1982 |
Prevention of dialysis-induced hypoxemia by bicarbonate dialysis.
Topics: Acetates; Bicarbonates; Blood; Blood Gas Analysis; Humans; Hydrogen-Ion Concentration; Hypoxia; Kidney Failure, Chronic; Partial Pressure; Renal Dialysis | 1980 |
Metabolites of glucose in the blood of patients with renal failure.
Topics: 2,3-Diphosphoglycerate; Acetaldehyde; Acetates; Acetoin; Adult; Aged; Blood Glucose; Butylene Glycols; Diphosphoglyceric Acids; Female; Humans; Kidney Failure, Chronic; Lactates; Male; Middle Aged; Pyruvates; Uremia | 1981 |
[Comparison of acetate and bicarbonate in hemodialytic treatment. Echocardiographic and polycardiographic study of the left ventricle].
Topics: Acetates; Adult; Bicarbonates; Echocardiography; Female; Heart; Heart Function Tests; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction; Renal Dialysis | 1981 |
Correlation between plasma sodium acetate concentration and systemic vascular resistances.
Topics: Acetates; Acetic Acid; Adult; Bicarbonates; Blood Pressure; Cardiac Output; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Vascular Resistance | 1981 |
Panel conference. Acetate versus bicarbonate in dialysis.
Topics: Acetates; Bicarbonates; Humans; Kidney Failure, Chronic; Renal Dialysis | 1981 |
Improved lipid profiles with bicarbonate dialysis.
Topics: Acetates; Adult; Aged; Bicarbonates; Cholesterol; Cholesterol, HDL; Female; Humans; Kidney Failure, Chronic; Lipids; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Middle Aged; Renal Dialysis; Triglycerides | 1980 |
Studies with pre-treatment of milk with calcium acetata to reduce the phosphate content.
Topics: Acetates; Acetic Acid; Animals; Cattle; Chemical Precipitation; Humans; Infant; Kidney Failure, Chronic; Milk; Phosphates | 1995 |
[Some indices of peripheral blood oxidative metabolism during acetate and bicarbonate hemodialysis in patients with chronic uremia].
Topics: Acetates; Adult; Bicarbonates; Erythrocytes; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Renal Dialysis; Superoxide Dismutase; Superoxides | 1994 |
Acid dialysate correction of metabolic alkalosis in renal failure.
Topics: Acetates; Acetic Acid; Alkalosis; Dialysis Solutions; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1995 |
Changes in plasma levels of vasoactive substances during routine acetate and bicarbonate hemodialysis.
Topics: Acetates; Aged; Aged, 80 and over; Bicarbonates; Buffers; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neuropeptides; Renal Dialysis; Time Factors | 1994 |
Acetate-free biofiltration: acidosis correction and cardiovascular stability.
Topics: Acetates; Acidosis; Bicarbonates; Cardiovascular Diseases; Evaluation Studies as Topic; Gastrointestinal Diseases; Hemodiafiltration; Hemodialysis Solutions; Hemodynamics; Humans; Kidney Failure, Chronic; Pain | 1994 |
Correction of metabolic acidosis and changes in plasma acetate levels in acetate and bicarbonate dialyses and acetate-free biofiltration.
Topics: Acetates; Acidosis; Bicarbonates; Hemodiafiltration; Hemodialysis Solutions; Hemodynamics; Humans; Hydrogen-Ion Concentration; Hypotension; Kidney Failure, Chronic; Renal Dialysis | 1994 |
Newly developed economical and efficient push/pull hemodiafiltration.
Topics: Acetates; Acid-Base Imbalance; beta 2-Microglobulin; Bicarbonates; Drug Contamination; Endotoxins; Equipment Design; Hemodiafiltration; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Sodium; Urea | 1994 |
Acetate-free biofiltration: the lessons we learned from 8 years' experience.
Topics: Acetates; Acidosis; Aged; Bicarbonates; Chlorides; Electric Conductivity; Hemodiafiltration; Hemodialysis Solutions; Hemodynamics; Humans; Kidney Failure, Chronic; Middle Aged; Retrospective Studies | 1994 |
Contribution of dialysis to endogenous oxalate production in patients with chronic renal failure.
Topics: Acetates; Bicarbonates; Buffers; Dialysis Solutions; Female; Glycolates; Humans; Indicator Dilution Techniques; Kidney Failure, Chronic; Kinetics; Male; Mass Spectrometry; Oxalates; Oxalic Acid; Peritoneal Dialysis, Continuous Ambulatory | 1994 |
Hemoglobin oxygen affinity and acid-base status in blood of chronic hemodialysis patients.
Topics: 2,3-Diphosphoglycerate; Acetates; Acid-Base Equilibrium; Adult; Aged; Bicarbonates; Carbon Dioxide; Dialysis Solutions; Diphosphoglyceric Acids; Female; Hemoglobins; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Male; Middle Aged; Oxygen; Renal Dialysis | 1994 |
[Hemodialysis with bicarbonate 30 mEq/l versus 34 mEq/l and acetate: better hemodynamic tolerance and electrolyte and acid-base homeostasis].
Topics: Acetates; Acid-Base Equilibrium; Adult; Analysis of Variance; Bicarbonates; Evaluation Studies as Topic; Female; Hemodialysis Solutions; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Prospective Studies; Renal Dialysis; Time Factors; Water-Electrolyte Balance | 1994 |
Plasma catecholamine concentration and dopamine-beta-hydroxylase activity during haemodialysis with acetate or bicarbonate at different sodium concentrations in hypotensive patients.
Topics: Acetates; Acetic Acid; Adult; Blood Pressure; Blood Pressure Determination; Dopamine; Dopamine beta-Hydroxylase; Epinephrine; Female; Humans; Kidney Failure, Chronic; Male; Norepinephrine; Renal Dialysis; Sodium Bicarbonate | 1993 |
Study of ceruloplasmin in renal insufficiency.
Topics: Acetates; Acetic Acid; Adult; Ammonium Sulfate; Ceruloplasmin; Chromatography; Electrophoresis, Polyacrylamide Gel; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1993 |
New reinfusate composition in high UF haemodiafiltration: electrolyte solution combined with bicarbonate.
Topics: Acetates; Acetic Acid; Acid-Base Equilibrium; Aged; Bicarbonates; Electrolytes; Evaluation Studies as Topic; Female; Hemodialysis Solutions; Hemofiltration; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Water-Electrolyte Balance | 1993 |
Our experience with acetate-free biofiltration.
Topics: Acetates; Acidosis; Bicarbonates; Biocompatible Materials; Blood Pressure; Electrolytes; Female; Humans; Kidney Failure, Chronic; Male; Membranes, Artificial; Renal Dialysis | 1995 |
[Acid-base equilibrium of peritoneal dialysis (CAPD) patients utilizing acetate, lactate, bicarbonate].
Topics: Acetates; Acid-Base Equilibrium; Bicarbonates; Blood Gas Analysis; Dialysis Solutions; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Lactates; Lactic Acid; Peritoneal Dialysis, Continuous Ambulatory; Water-Electrolyte Balance | 1995 |
Plasma glucose turnover and oxidation during hemodialysis: nutritional effect of dialysis fluid.
Topics: Acetates; Adult; Aged; Blood Glucose; Carbohydrates; Dialysis Solutions; Energy Metabolism; Fatty Acids; Female; Glucose; Humans; Kidney Failure, Chronic; Male; Middle Aged; Nutritive Value; Oxidation-Reduction; Renal Dialysis | 1997 |
Influence of acetate and bicarbonate hemodialysis on the plasma erythropoietin concentration in patients with chronic renal failure.
Topics: Acetates; Adult; Anemia; Bicarbonates; Biocompatible Materials; Blood Gas Analysis; Cellulose; Dialysis Solutions; Erythrocyte Count; Erythropoietin; Female; Ferritins; Hematocrit; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Oxygen; Partial Pressure; Radioimmunoassay; Renal Dialysis | 1997 |
Cardiac arrhythmias in patients on maintenance hemodialysis.
Topics: Acetates; Adult; Arrhythmias, Cardiac; Case-Control Studies; Echocardiography; Electrocardiography, Ambulatory; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Time Factors | 1997 |
Hemodialysis associated hypoxia extends into the post-dialysis period.
Topics: Acetates; Adult; Aged; Bicarbonates; Female; Humans; Hypoxia; Kidney Failure, Chronic; Male; Middle Aged; Oximetry; Oxygen; Renal Dialysis; Time Factors | 1997 |
Influence of pH on in vitro disintegration of phosphate binders.
Topics: Absorption; Acetates; Administration, Oral; Aluminum Hydroxide; Antacids; Calcium; Calcium Carbonate; Capsules; Chemistry, Pharmaceutical; Forecasting; Gastric Juice; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Secretions; Kidney Failure, Chronic; Phosphates; Solubility; Tablets; Time Factors; Water | 1998 |
Effects of acetate or bicarbonate dialysis solutions on serum HDL and HDL subfractions of patients undergoing haemodialysis.
Topics: Acetates; Adult; Apolipoproteins; Bicarbonates; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Lipids; Lipoproteins, HDL; Male; Middle Aged; Renal Dialysis; Time Factors | 1999 |
Trace Metals' abnormalities in hemodialysis patients: relationship with medications.
Topics: Acetates; Aluminum; Aluminum Hydroxide; Cadmium; Calcitriol; Calcium; Calcium Carbonate; Calcium Compounds; Case-Control Studies; Chelating Agents; Chi-Square Distribution; Copper; Cross-Sectional Studies; Erythropoietin; Female; Hematocrit; Humans; Hydroxycholecalciferols; Kidney Failure, Chronic; Lead; Male; Mercury; Metals; Middle Aged; Phosphates; Renal Dialysis; Spectrophotometry, Atomic; Sucralfate; Trace Elements; Zinc | 2000 |
Postherpetic pain control with concomitant illness?
Topics: Acetates; Aged; Aged, 80 and over; Amines; Analgesics; Analgesics, Opioid; Biological Availability; Comorbidity; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Heart Failure; Herpes Zoster Oticus; Humans; Kidney Failure, Chronic; Male; Meperidine; Metabolic Clearance Rate; Patient Selection | 2001 |
Gabapentin neurotoxicity in a chronic haemodialysis patient.
Topics: Acetates; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Epilepsy; Epilepsy, Absence; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Kidney Failure, Chronic; Nervous System; Renal Dialysis | 2001 |
Gabapentin toxicity requiring intubation in a patient receiving long-term hemodialysis.
Topics: Acetates; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Drug Overdose; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hypoxia; Intubation; Kidney Failure, Chronic; Middle Aged; Renal Dialysis | 2002 |
Mechanism of post dialysis hyperventilation in patients with chronic renal insufficiency.
Topics: Acetates; Adult; Bicarbonates; Carbon Dioxide; Female; Humans; Hydrogen-Ion Concentration; Hyperventilation; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1976 |
An automated technique for the analysis of plasma guanidino acids, and some findings in chronic renal disease.
Topics: Acetates; Arginine; Autoanalysis; Butyrates; Carboxylic Acids; Chromatography, Affinity; Chromatography, Ion Exchange; Creatinine; Guanidines; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Methods; Propionates; Renal Dialysis; Succinates | 1975 |
Acetate intolerance and an inhibitor of acetate utilization in hemodialysis patients.
Topics: Acetates; Adult; Aged; Blood Chemical Analysis; Carbon Radioisotopes; Cells, Cultured; Humans; Kidney Failure, Chronic; Lymphocytes; Male; Middle Aged; Radioisotope Dilution Technique; Reference Values; Renal Dialysis | 1979 |
Incidence and significance of rising blood acetate levels during hemodialysis.
Topics: Acetates; Acute Kidney Injury; Adult; Child; Humans; Hypotension; Kidney Failure, Chronic; Liver Diseases; Renal Dialysis | 1979 |
Comparison of the effects of lactate and acetate on clinical peritoneal clearances.
Topics: Acetates; Creatinine; Humans; Inulin; Kidney Failure, Chronic; Lactates; Peritoneal Dialysis; Peritoneum; Permeability; Proteins; Solutions; Urea | 1979 |
[Study of acetate metabolism in maintenance hemodialysis patients (author's transl)].
Topics: Acetates; Adult; Aged; Buffers; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1979 |
Gas-chromatographic method for plasma acetate analysis in acetate-intolerance studies.
Topics: Acetates; Acidosis; Adolescent; Adult; Aged; Chromatography, Gas; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1978 |
Respiratory gas exchange by high-efficiency hemodialyzers.
Topics: Acetates; Acid-Base Equilibrium; Adult; Bicarbonates; Blood Gas Analysis; Carbon Dioxide; Humans; Kidney Failure, Chronic; Middle Aged; Oxygen; Renal Dialysis; Respiration | 1978 |
Effect of acetate administration on blood lipids.
Topics: Acetates; Cholesterol; Humans; Hyperlipidemias; Kidney Failure, Chronic; Lipids; Renal Dialysis | 1978 |
[Hemodynamic effects of acetate on the cardiovascular system (author's transl)].
Topics: Acetates; Adolescent; Adult; Blood Pressure; Depression, Chemical; Female; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction | 1978 |
Effect of acetate on serum lipids in maintenance hemodialysis.
Topics: Acetates; Adult; Bicarbonates; Cholesterol; Fatty Acids, Nonesterified; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Triglycerides | 1977 |
Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
Topics: Acetates; Adult; Animals; Antigens; Arginine; Chromatography, Gel; Fasting; Female; Glucagon; Glucose; Humans; Kidney Failure, Chronic; Male; Molecular Weight; Nephrectomy; Rats; Stress, Physiological; Trypsin | 1976 |
Continuous measurements of oxygen saturation during haemodialysis.
Topics: Acetates; Acetic Acid; Adult; Aged; Bicarbonates; Data Display; Humans; Hypoxia; Kidney Failure, Chronic; Middle Aged; Oximetry; Oxygen; Renal Dialysis | 1992 |
[Effect of carbon dioxide (CO2) pressure on minute ventilation, parameters of gas exchange and blood gases during hemodialysis using fluid containing acetate and bicarbonate buffers].
Topics: Acetates; Adult; Aged; Bicarbonates; Buffers; Carbon Dioxide; Female; Hemodialysis Solutions; Humans; Hypoxia; Kidney Failure, Chronic; Male; Middle Aged; Oxygen; Renal Dialysis; Respiration | 1992 |
[Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
Topics: Acetates; Acetic Acid; Adolescent; Adult; Biocompatible Materials; Cellulose; Creatinine; Female; Formaldehyde; Hemodialysis Solutions; Humans; Hydrogen Peroxide; Kidney Failure, Chronic; Male; Membranes, Artificial; Middle Aged; Renal Dialysis; Sodium Hypochlorite; Time Factors | 1992 |
[Cytokines on hemodialysis].
Topics: Acetates; Dialysis Solutions; Humans; Interleukin-1; Kidney Failure, Chronic; Renal Dialysis | 1992 |
[Vapor-phase gas chromatographic determination of acetate in the blood].
Topics: Acetates; Adult; Aged; Chromatography, Gas; Humans; Kidney Failure, Chronic; Middle Aged; Reference Values; Renal Dialysis | 1990 |
Serum calcium increases the incidence of arrhythmias during acetate hemodialysis.
Topics: Acetates; Arrhythmias, Cardiac; Calcium; Dialysis Solutions; Electrolytes; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1992 |
[The course of chronic kidney failure during acetate and bicarbonate hemodialysis].
Topics: Acetates; Adolescent; Adult; Bicarbonates; Evaluation Studies as Topic; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Time Factors | 1991 |
[Removal of inorganic phosphate on hemodialysis].
Topics: Acetates; Bicarbonates; Cellulose; Dialysis Solutions; Humans; Kidney Failure, Chronic; Membranes, Artificial; Phosphates; Renal Dialysis | 1991 |
[Phosphate binders for therapy of hyperphosphatemia causing secondary hyperparathyroidism and renal osteodystrophy in patients with chronic renal failure].
Topics: Acetates; Acetic Acid; Allantoin; Aluminum Hydroxide; Bicarbonates; Chronic Kidney Disease-Mineral and Bone Disorder; Citrates; Citric Acid; Drug Combinations; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Magnesium Hydroxide; Phosphates | 1991 |
Are there advantages to bicarbonate dialysis as a standard procedure for chronic hemodialysis in children?
Topics: Acetates; Bicarbonates; Child; Humans; Kidney Failure, Chronic; Renal Dialysis | 1991 |
Net ultrafiltration volume (nUFV) during IPD with acetate or lactate dialysis solutions.
Topics: Acetates; Dialysis Solutions; Humans; Kidney Failure, Chronic; Lactates; Lactic Acid; Middle Aged; Osmolar Concentration; Peritoneal Dialysis; Peritoneum; Peritonitis; Time Factors; Ultrafiltration | 1990 |
Medication review: an alternative phosphate binder--calcium acetate.
Topics: Acetates; Acetic Acid; Humans; Kidney Failure, Chronic; Phosphates | 1991 |
[The effect of acetate and bicarbonate hemodialysis on protein and lipid metabolism in patients with chronic kidney failure].
Topics: Acetates; Acid-Base Equilibrium; Adult; Bicarbonates; Dialysis Solutions; Evaluation Studies as Topic; Female; Humans; Kidney Failure, Chronic; Lipids; Male; Molecular Weight; Peptides; Renal Dialysis; Time Factors | 1990 |
[The clinical value of correction of acidosis by acetate-free biofiltration in patients on regular dialysis treatment].
Topics: Acetates; Acidosis; Adult; Bicarbonates; Dialysis Solutions; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Renal Dialysis | 1990 |
Kinetic modeling of intradialytic and interdialytic pH shifts during and after acetate and bicarbonate hemodialysis.
Topics: Acetates; Bicarbonates; Computer Simulation; Dialysis Solutions; Erythrocytes; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Models, Biological; Renal Dialysis | 1990 |
Regulation of plasma aldosterone during hemodialysis.
Topics: Acetates; Adolescent; Adult; Aged; Aldosterone; Angiotensin II; Bicarbonates; Dialysis Solutions; Humans; Kidney Failure, Chronic; Middle Aged; Potassium; Renal Dialysis; Sodium | 1990 |
The effect of acetate on ventilation in haemodialysis patients.
Topics: Acetates; Adult; Blood Gas Analysis; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Plethysmography; Renal Dialysis; Respiration; Respiratory Function Tests | 1989 |
Acid base correction in bicarbonate CAPD patients.
Topics: Acetates; Acid-Base Equilibrium; Bicarbonates; Buffers; Dialysis Solutions; Humans; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory | 1989 |
CAPD in a large population: a 7-year experience.
Topics: Acetates; Adult; Aged; Bicarbonates; Dialysis Solutions; Hemofiltration; Humans; Kidney Failure, Chronic; Middle Aged; Patient Dropouts; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Renal Dialysis; Survival Analysis; Survival Rate | 1989 |
Time of administration of calcium acetate and phosphate binding.
Topics: Acetates; Acetic Acid; Adult; Humans; Kidney Failure, Chronic; Phosphates | 1989 |
[Use of bicarbonate dialysis in patients with terminal renal failure].
Topics: Acetates; Acid-Base Equilibrium; Bicarbonates; Blood Gas Analysis; Dialysis Solutions; Humans; Kidney Failure, Chronic; Renal Dialysis | 1989 |
Pulmonary gas exchange during dialysis in patients with obstructive lung disease.
Topics: Acetates; Bicarbonates; Dialysis Solutions; Humans; Hypoxia; Kidney Failure, Chronic; Lung Diseases, Obstructive; Male; Middle Aged; Pulmonary Gas Exchange; Renal Dialysis | 1989 |
Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study.
Topics: Acetates; Acetic Acid; Adult; Aluminum; Calcium Carbonate; Citrates; Citric Acid; Diet; Humans; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; Phosphorus; Reference Values | 1989 |
Effects of L-carnitine administration on short-chain fatty acid (acetic acid) and long-chain fatty acid metabolism during hemodialysis.
Topics: Acetates; Acetoacetates; Adult; Aged; Carnitine; Fatty Acids; Fatty Acids, Nonesterified; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Triglycerides | 1989 |
Effect of etodolac in patients with moderate renal impairment compared with normal subjects.
Topics: Acetates; Adolescent; Adult; Aged; Chlorides; Creatinine; Drug Evaluation; Etodolac; Female; Humans; Infusions, Parenteral; Kidney Failure, Chronic; Male; Middle Aged; Potassium; Sodium | 1985 |
Effects of nonsteroidal antiinflammatory drugs on renal function in patients with renal insufficiency and in cirrhotics.
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Dinoprostone; Etodolac; Humans; Indomethacin; Ketoprofen; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Liver Cirrhosis, Alcoholic; Prostaglandins E; Sulindac | 1986 |
Patient-related factors influencing the plasma acetate concentration during haemodialysis.
Topics: Acetates; Age Factors; Body Surface Area; Creatinine; Female; Hematocrit; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Renal Dialysis; Serum Albumin; Sex Factors; Statistics as Topic; Time Factors | 1987 |
The renin-angiotensin-aldosterone system during haemodialysis with acetate or bicarbonate at different dialysate sodium concentrations.
Topics: Acetates; Adult; Aldosterone; Angiotensin II; Bicarbonates; Female; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Renin-Angiotensin System; Sodium | 1987 |
NMR monitoring of the energy status of skeletal muscle during hemodialysis using acetate.
Topics: Acetates; Acetic Acid; Adenosine Triphosphate; Dialysis Solutions; Energy Metabolism; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Magnetic Resonance Spectroscopy; Muscles; Renal Dialysis | 1988 |
[Bicarbonate hemodialysis in the therapy of chronic kidney failure].
Topics: Acetates; Adolescent; Adult; Bicarbonates; Dialysis Solutions; Evaluation Studies as Topic; Female; Hemodialysis Solutions; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1988 |
Hemodynamic changes during acetate dialysis, bicarbonate dialysis and hemofiltration.
Topics: Acetates; Aged; Bicarbonates; Buffers; Female; Hemodynamics; Hemofiltration; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Vascular Resistance; Water-Electrolyte Balance | 1988 |
Effects of acetate during regular hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Bicarbonates; Buffers; Fatty Acids, Nonesterified; Female; Hormones; Humans; Kidney Failure, Chronic; Lipolysis; Male; Renal Dialysis | 1988 |
Effects of acetate versus bicarbonate hemodialysis on left ventricular size and function.
Topics: Acetates; Adult; Aged; Bicarbonates; Echocardiography; Female; Heart Ventricles; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Systole; Ventricular Function | 1987 |
Future trends in biocompatibility aspects of hemodialysis and related therapies.
Topics: Acetates; Acetylmuramyl-Alanyl-Isoglutamine; Biocompatible Materials; Blood; Complement C5; Complement C5a; Humans; Interleukin-1; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory; Pyrogens; Renal Dialysis; Ultrafiltration | 1986 |
Hypersensitivity reactions related to acetate dialyzate and cellulose acetate membrane.
Topics: Acetates; Adult; Anaphylaxis; Cellulose; Female; Humans; Kidney Failure, Chronic; Membranes, Artificial; Renal Dialysis | 1987 |
Myocardial impairment in chronic hemodialysis patients. Effect of acetate hemodialysis.
Topics: Acetates; Aged; Cardiac Output; Heart; Heart Failure; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pressure; Pulmonary Wedge Pressure; Renal Dialysis; Vascular Resistance; Water-Electrolyte Balance | 1986 |
Progressive calcifying peritonitis: a new complication of CAPD? Report of two cases.
Topics: Acetates; Aged; Calcinosis; Female; Humans; Kidney Failure, Chronic; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |
[The launching of bicarbonate dialysis in Pilsen].
Topics: Acetates; Acid-Base Equilibrium; Adult; Bicarbonates; Female; Humans; Kidney Failure, Chronic; Male; Renal Dialysis | 1986 |
Biocompatibility and hemodynamic studies during polycarbonate versus cuprophane membrane dialysis.
Topics: Acetates; Adult; Biocompatible Materials; Blood Pressure; Cardiac Output; Cellulose; Dental Cements; Female; Heart Rate; Hemodynamics; Humans; Kidney Failure, Chronic; Leukocyte Count; Male; Membranes, Artificial; Middle Aged; Oxygen; Partial Pressure; Polycarboxylate Cement; Renal Dialysis; Ultrafiltration | 1986 |
[Electroencephalographic changes in children dialyzed according to various protocols].
Topics: Acetates; Adolescent; Bicarbonates; Blood; Brain Diseases; Child; Electroencephalography; Female; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Ultrafiltration | 1986 |
Switch from acetate (Ac) to bicarbonate (Bi) dialysis: better dialysis tolerance but failure to improve acidosis and hypertriglyceridemia (HTG).
Topics: Acetates; Acidosis; Bicarbonates; Blood Pressure; Body Weight; Buffers; Hemodynamics; Humans; Hyperlipidemias; Kidney Failure, Chronic; Renal Dialysis; Triglycerides | 1985 |
A portable hemodialysis system with sorbent regeneration of dialysate: preliminary results.
Topics: Acetates; Aluminum; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Kinetics; Renal Dialysis; Water | 1985 |
Effect of hemodialysis on myocardial contractility.
Topics: Acetates; Adult; Bicarbonates; Blood Pressure; Cardiac Output; Humans; Kidney Failure, Chronic; Middle Aged; Myocardial Contraction; Renal Dialysis | 1985 |
Haemodynamic state in severe chronic renal failure. Pathophysiological aspects of cardiovascular function and the importance of bicarbonate dialysis.
Topics: Acetates; Adult; Bicarbonates; Blood Pressure; Carbon Dioxide; Cardiac Output; Electrocardiography; Female; Heart Rate; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pulmonary Circulation; Renal Dialysis | 1985 |
Physiologic approach to dialysis-induced hypoxemia. Effects of dialyzer material and dialysate composition.
Topics: Acetates; Adult; Aged; Bicarbonates; Carbon Dioxide; Cellulose; Complement Activation; Female; Humans; Hypoxia; Kidney Failure, Chronic; Leukopenia; Male; Membranes, Artificial; Methylmethacrylates; Middle Aged; Oxygen; Pulmonary Diffusing Capacity; Renal Dialysis | 1985 |
[Effects of the hemodialyzer on blood gases and acid-base equilibrium].
Topics: Acetates; Acid-Base Equilibrium; Adult; Bicarbonates; Carbon Dioxide; Female; Glomerulonephritis; Humans; Kidney Diseases, Cystic; Kidney Failure, Chronic; Middle Aged; Oxygen; Renal Dialysis | 1985 |
Acid-base balance in dialysis patients.
Topics: Acetates; Acid-Base Equilibrium; Acidosis; Bicarbonates; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Male; Middle Aged | 1985 |
On the effects of acetate during hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Bicarbonates; Carbon Dioxide; Humans; Kidney Failure, Chronic; Lactates; Pyruvates; Renal Dialysis | 1974 |
Peritoneal dialysis solutions.
Topics: Acetates; Acute Kidney Injury; Blood Urea Nitrogen; Calcium; Chlorides; Coma; Glucose; Humans; Hyperglycemia; Hypernatremia; Kidney Failure, Chronic; Lactates; Magnesium; Peritoneal Dialysis; Potassium; Sodium; Sorbitol | 1973 |
Concentrations in serum and urinary excretion of guanidine, 1-methylguanidine, and 1,1-dimethylguanidine in chronic renal failure.
Topics: Acetates; Arginine; Body Fluids; Chromatography, Ion Exchange; Creatine; Creatinine; Guanidines; Humans; Kidney Failure, Chronic; Spectrophotometry; Succinates; Uremia | 1973 |
Fluid secretion in isolated proximal straight renal tubules. Effect of human uremic serum.
Topics: Acetates; Aminohippuric Acids; Animals; Benzoates; Blood Urea Nitrogen; Creatinine; Female; Guanidines; Humans; Kidney Failure, Chronic; Kidney Tubules; Kidney Tubules, Proximal; Lactates; Male; Ouabain; Perfusion; Probenecid; Rabbits; Succinates; Time Factors; Urea; Uremia; Uric Acid | 1973 |
Acid-base status during the interdialytic period in patients maintained with chronic hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Adult; Bicarbonates; Carbon Dioxide; Female; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis | 1969 |
[Ionized calcium during hemodialysis in chronic renal insufficiency].
Topics: Acetates; Bone Diseases; Calcium; Chelating Agents; Heparin; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Methods; Renal Dialysis; Time Factors; Uremia | 1970 |
Acetate and bicarbonate in the correction of uraemic acidosis.
Topics: Acetates; Acidosis; Bicarbonates; Blood; Carbon Dioxide; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Liver Diseases; Sodium; Uremia | 1970 |
[Treatment of metabolic acidosis in patients with chronic renal insufficiency].
Topics: Acetates; Acidosis, Renal Tubular; Adult; Bicarbonates; Calcium; Citrates; Creatinine; Diet, Sodium-Restricted; Female; Glomerulonephritis; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Male; Potassium; Pyelonephritis; Sodium; Time Factors | 1971 |
Acid base balance in chronic hemodialysis.
Topics: Acetates; Acid-Base Equilibrium; Acidosis; Bicarbonates; Carbon Dioxide; Diet Therapy; Dietary Proteins; Humans; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Oxygen; Renal Dialysis; Uremia | 1968 |
Evidence that methylguanidine is retained in chronic renal failure.
Topics: Acetates; Butyrates; Chemistry, Clinical; Chromatography, Paper; Guanidines; Humans; Kidney Failure, Chronic; Propionates; Succinates; Uremia | 1968 |
Metabolic effects of haemodialysis against glucose- and acetate-containing solutions.
Topics: Acetates; Acute Kidney Injury; Blood Glucose; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Lactates; Pyruvates; Renal Dialysis | 1969 |